ERBB2 and breast neoplasm: In summary, we identified a BRCA1 Deficient-Like metagene that is enriched in HER2+ brain metastases when compared with HER2+ primary tumors, and in an independent data set confirmed the enrichment of the metagene in brain metastases as compared to bone metastases, lung metastases, and primary breast tumors.